UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029159
Receipt number R000033341
Scientific Title Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancer
Date of disclosure of the study information 2017/10/01
Last modified on 2021/05/25 16:00:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Acronym

Sentinel node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Scientific Title

Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Scientific Title:Acronym

Sentinel node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Region

Japan


Condition

Condition

colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To invastigate the identification rates of sentinel lymph node guided by indocyanine green fluorescence imaging

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The identification rate of sentinel lymph node

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

During cololectomy, Indocyanine green is submucosally injected via endoscopy around tumor and sentinel lymph nodes are picked up using indocyanine green fluorescence imaging.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically proven adenocarcinoma of colon or rectum adenocarcinoma.
2) solitary tumor.
3) cT2 or cT3 or cT4a or cT4b.
4) cN0.
5) D3 lymph node dissection is planned to be performed.
6) Age of 20 years or older.
7) No history of colorectomy.
8) Written informed consent.

Key exclusion criteria

1) Allergy for indocyanine green or iodine.
2) Cannot enroll to this study for any other reasons.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaki Mori

Organization

Osaka University

Division name

Department of Gastroenterological Surgery

Zip code


Address

2-2, Yamadaoka, Suita, Osaka

TEL

+81-6-6879-3251

Email

mmori@gesurg.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hidekazu Takahashi

Organization

Osaka University

Division name

Department of Gastroenterological Surgery

Zip code


Address

2-2, Yamadaoka, Suita, Osaka

TEL

+81-6-6879-3251

Homepage URL


Email

htakahashi@gesurg.med.osaka-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterological Surgery, Osaka University

Institute

Department

Personal name



Funding Source

Organization

Osaka University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 15 Day

Last modified on

2021 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033341


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name